Clinical Trials Browser

Phase 2 × Active not recruiting × Prostatic Neoplasms, Castration-Resistant × Clear all

NCT03431350 2026-05-11

QUEST

Phase 2 Active not recruiting

136 enrolled 29 charts

Prostatic Neoplasms, Castration-Resistant

NCT07047118 2026-05-01

A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 2 Active not recruiting

Prostatic Neoplasms, Prostatic Neoplasms, Castration-Resistant